Article

Can cannabis reduce agitation in dementia patients?

Leave a Comment

Your email address will not be published. Required fields are marked *

1 Comment
  • Fred Ryan says:

    Anecdotally, it appears that cannabanoids offer remarkably helpful results to people with early dementia (and for their care-givers), plus those suffering bi-polar and other psychotic difficulties. Yet the researchers you quote all seem determined to dismiss this chemical because of various easy-to-resolve difficulties (uneven quality, etc ). Would not a genuine line of investigation seek to actually surmount these difficulties to get at the potential here for aid? Finally, the drug is legal and can be studied . . . but now faces prejudices among the researchers themselves?
    A neighbour (across the street here) has been diagnosed as bipolar (when it was called that) — has had two ambulance episodes to the hospital due to difficulties with his lithium prescription, plus family difficulties, until he decided to try cannabis (legally purchased). He — and his care-giving sister — claim he has not felt this capable and functional for years. One unofficial example … but such instances are ignored by researchers due to years of bad press and public disapproval. Is this how medical research should be conducted, swayed by researchers’ prejudices?
    Thanks.

Author

Paul Taylor

Contributor

Paul Taylor is a health journalist and former Patient Navigation Advisor at Sunnybrook Health Sciences Centre, where he provided advice and answered questions from patients and their families. Paul will continue to write occasional columns for Healthy Debate.

Republish this article

Republish this article on your website under the creative commons licence.

Learn more